Sign in
4

Changes in Ownership

RECURSION PHARMACEUTICALS, INC. Filed Acc 0001209191-23-053196

Director sold 8,885 shares at $6.58 ($58,483)

From the SEC's structured data for this filing

Trades in this filing

Borgeson Blake · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-10-17 Sale : show line 1 in the form −8,885 $6.58 $58,483 7,425,190 D
Open-market sales · 8,885 sh · avg $6.58 · $58,483
Loading xslF345X05/doc4.xml…